HistoSonics wins Europe’s CE mark for histotripsy system

HistoSonics wins Europe’s CE mark for histotripsy system is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-07-14

HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.

Source: MedTech Dive